LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 128 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.94 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $92,000 | +37.3% | 14,563 | +43.9% | 0.01% | +100.0% |
Q4 2018 | $67,000 | -64.2% | 10,117 | -42.1% | 0.00% | -71.4% |
Q3 2018 | $187,000 | -20.8% | 17,481 | -11.2% | 0.01% | -12.5% |
Q2 2018 | $236,000 | +33.3% | 19,676 | -4.9% | 0.02% | +33.3% |
Q1 2018 | $177,000 | -45.2% | 20,683 | -8.2% | 0.01% | -70.7% |
Q1 2017 | $323,000 | – | 22,535 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |